These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 16973014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Attention deficit hyperactivity disorder in children.
    Pritchard D.
    Clin Evid; 2005 Jun; (13):266-79. PubMed ID: 16135263
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clonidine in attention deficit hyperactivity disorder.
    Hart-Santora D, Hart LL.
    Ann Pharmacother; 1992 Jan; 26(1):37-9. PubMed ID: 1606344
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Minimal brain dysfunction].
    Ruel JM.
    Vie Med Can Fr; 1974 Aug; 3(8):758-60. PubMed ID: 4410153
    [No Abstract] [Full Text] [Related]

  • 9. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.
    Hunt RD, Minderaa RB, Cohen DJ.
    Psychopharmacol Bull; 1986 Aug; 22(1):229-36. PubMed ID: 3523578
    [No Abstract] [Full Text] [Related]

  • 10. The role of methylphenidate and dextroamphetamine in hyperactivity in children.
    Solomons G.
    J Iowa Med Soc; 1971 Nov; 61(11):658-61. PubMed ID: 4107192
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of stimulant medication with children.
    Phillips S.
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract] [Full Text] [Related]

  • 13. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 14. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA.
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic interventions to prevent delinquency in hyperactive boys.
    Satterfield JH, Satterfield BT, Schell AM.
    J Am Acad Child Adolesc Psychiatry; 1987 Jan; 26(1):56-64. PubMed ID: 3584002
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG.
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.